BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20859706)

  • 1. Expression change of ezrin as a prognostic factor in primary osteosarcoma.
    Wang YF; Shen JN; Xie XB; Wang J; Huang G
    Med Oncol; 2011 Dec; 28 Suppl 1():S636-43. PubMed ID: 20859706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
    Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
    Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
    Mu Y; Zhang H; Che L; Li K
    Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
    Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Role of Ezrin and HER2/neu Expression in Osteosarcoma.
    Abdou AG; Kandil M; Asaad NY; Dawoud MM; Shahin AA; Abd Eldayem AF
    Appl Immunohistochem Mol Morphol; 2016; 24(5):355-63. PubMed ID: 26067138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.
    Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K
    Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma.
    Boldrini E; Peres SV; Morini S; de Camargo B
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e213-7. PubMed ID: 20562647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
    Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
    PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis.
    Zhao DH; Zhu J; Wang WB; Dong F; Zhang Q; Fan HW; Zhang JZ; Wang YM
    ScientificWorldJournal; 2014; 2014():837543. PubMed ID: 25544963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of elevated ezrin in patients with osteosarcoma.
    Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
    Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis.
    Ogino W; Takeshima Y; Mori T; Yanai T; Hayakawa A; Akisue T; Kurosaka M; Matsuo M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):435-9. PubMed ID: 17609619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
    Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
    Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
    Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
    Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Ezrin correlates with lung metastasis in Chinese patients with osteosarcoma.
    Xu-Dong S; Zan S; Shui-er Z; Li-na T; Wen-xi Y; Feng L; Yang Y
    Clin Invest Med; 2009 Apr; 32(2):E180-8. PubMed ID: 19331807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma.
    Salas S; de Pinieux G; Gomez-Brouchet A; Larrousserie F; Leroy X; Aubert S; Decouvelaere AV; Giorgi R; Fernandez C; Bouvier C
    Virchows Arch; 2009 Jan; 454(1):81-7. PubMed ID: 19050913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell.
    Di Cristofano C; Leopizzi M; Miraglia A; Sardella B; Moretti V; Ferrara A; Petrozza V; Della Rocca C
    Mod Pathol; 2010 Jul; 23(7):1012-20. PubMed ID: 20348881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
    Wang Z; He ML; Zhao JM; Qing HH; Wu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.